BIOVERATIV INC. Increase (Decrease) in Other Operating Assets
BIOVERATIV INC. reported Increase (Decrease) in Other Operating Assets of $45.60 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2018-02-14
- BIOVERATIV INC. increase (decrease) in other operating assets for the quarter ending 2017-12-31 was -$14.60M, a 207.35% decline year-over-year.
- BIOVERATIV INC. increase (decrease) in other operating assets for the quarter ending 2017-09-30 was $22.20M, a 326.92% increase year-over-year.
- BIOVERATIV INC. increase (decrease) in other operating assets for the quarter ending 2017-06-30 was $12.50M, a 331.03% increase year-over-year.
- BIOVERATIV INC. increase (decrease) in other operating assets for the quarter ending 2017-03-31 was $25.50M, a 2733.33% increase year-over-year.
- BIOVERATIV INC. increase (decrease) in other operating assets for fiscal 2017 was $45.60M, a 101.77% increase from fiscal 2016.
- BIOVERATIV INC. increase (decrease) in other operating assets for fiscal 2016 was $22.60M, a 318.52% increase from fiscal 2015.
- BIOVERATIV INC. increase (decrease) in other operating assets for fiscal 2015 was $5.40M.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$14.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $7.60M derived: sum of 2 quarters · filed 2018-02-14 | $20.10M derived: sum of 3 quarters · filed 2018-02-14 | $45.60M 10-K · filed 2018-02-14 |
| 2017-09-30 | $22.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $34.70M derived: sum of 2 quarters · filed 2017-10-27 | $60.20M 10-Q · filed 2017-10-27 | $73.80M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $12.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $38.00M 10-Q · filed 2017-08-03 | $51.60M derived: sum of 3 quarters · filed 2018-02-14 | $56.80M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $25.50M 10-Q · filed 2017-05-12 | $39.10M derived: sum of 2 quarters · filed 2018-02-14 | $44.30M derived: sum of 3 quarters · filed 2018-02-14 | $47.20M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $13.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $18.80M derived: sum of 2 quarters · filed 2018-02-14 | $21.70M derived: sum of 3 quarters · filed 2018-02-14 | $22.60M 10-K · filed 2018-02-14 |
| 2016-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $8.10M derived: sum of 2 quarters · filed 2017-10-27 | $9.00M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $3.80M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $900.00K 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | $5.40M 10-K · filed 2018-02-14 |